UnitedHealth Group (NYSE:UNH) had its price objective upped by Barclays from $265.00 to $280.00 in a research report released on Friday morning. Barclays currently has an overweight rating on the healthcare conglomerate’s stock.

UNH has been the subject of a number of other reports. Jefferies Financial Group raised their price target on UnitedHealth Group from $270.00 to $311.00 and gave the stock a buy rating in a research note on Wednesday, October 3rd. Morgan Stanley raised their price target on UnitedHealth Group from $278.00 to $305.00 and gave the stock an overweight rating in a research note on Wednesday, September 5th. Zacks Investment Research lowered UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, September 18th. ValuEngine raised UnitedHealth Group from a hold rating to a buy rating in a research note on Tuesday, October 2nd. Finally, Cantor Fitzgerald reissued a buy rating and set a $300.00 price target on shares of UnitedHealth Group in a research note on Thursday, July 5th. One research analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group presently has a consensus rating of Buy and a consensus target price of $279.26.

Shares of NYSE:UNH traded up $2.49 during trading on Friday, hitting $259.61. The company had a trading volume of 3,872,525 shares, compared to its average volume of 3,079,966. The firm has a market capitalization of $256.06 billion, a price-to-earnings ratio of 25.78, a PEG ratio of 1.58 and a beta of 0.73. UnitedHealth Group has a one year low of $186.00 and a one year high of $272.07. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.75 and a quick ratio of 0.75.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.04 by $0.10. The business had revenue of $56.09 billion during the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same period last year, the company earned $2.46 EPS. As a group, analysts expect that UnitedHealth Group will post 12.72 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th were given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date was Thursday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.75%.

In other news, EVP D Ellen Wilson sold 15,393 shares of UnitedHealth Group stock in a transaction on Friday, August 24th. The stock was sold at an average price of $264.29, for a total value of $4,068,215.97. Following the transaction, the executive vice president now directly owns 66,402 shares in the company, valued at approximately $17,549,384.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kenneth Irwin Shine sold 177 shares of UnitedHealth Group stock in a transaction on Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total value of $45,262.44. Following the completion of the transaction, the director now owns 29,053 shares in the company, valued at $7,429,433.16. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 94,745 shares of company stock valued at $24,995,290. 0.87% of the stock is currently owned by corporate insiders.

Several large investors have recently made changes to their positions in UNH. Welch Group LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $106,000. Blue Chip Partners Inc. purchased a new position in UnitedHealth Group during the 2nd quarter worth $107,000. Northwest Wealth Management LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $117,000. Fort L.P. purchased a new position in UnitedHealth Group during the 2nd quarter worth $119,000. Finally, Kiley Juergens Wealth Management LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $178,000. Institutional investors and hedge funds own 85.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Determine Your Level of Risk Tolerance

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.